Generare
Health
· Headquartered in France 🇫🇷
Track Generare
— get Health deals in free daily digest
Overview
Generare Bioscience SAS, a Paris-based biotechnology company, has raised €20 million (approximately $23.3 million) in an early-stage funding round co-led by Alven and Daphni. The funding aims to support the company's innovative approach to generating molecular data for drug development using artificial intelligence. Existing investors, including Galion.exe, Teampact Ventures, and Vives Partners, also participated in this Series A round.
Products
Loading...
Synthesising company profile
Reading press coverage to extract founders, customers, traction signals and competitive positioning…
Recent Announcements
Investors: Alven, Daphni, Galion.exe, Teampact Ventures, Vives Partners
Generare Bioscience SAS, a Paris-based biotechnology company, has raised €20 million (approximately $23.3 million) in an early-stage funding round co-led by Alven and Daphni. The funding aims to support the company's innovative approach to generating molecular data for drug development using artificial intelligence. Existing investors, including Galion.exe, Teampact Ventures, and Vives Partners, also participated in this Series A round.
More Health Deals
Market Map
View thousands of companies by category in our market map:
